GO:0036120 cellular response to platelet-derived growth factor stimulus: Signaling Pathway, Genes, Functions and Research Methods
Research-grade guide for scientists and biopharma professionals
Key Takeaways
• GO:0036120 describes all cellular changes (movement, secretion, enzyme production, gene expression) triggered by platelet-derived growth factor (PDGF) [1,3].
• PDGF is a major mitogen and chemoattractant for connective tissue cells, including fibroblasts, smooth muscle cells, and pericytes [3,7].
• The response involves activation of PDGF receptors and downstream signaling cascades such as PI3K/Akt and MAPK, leading to proliferation, migration, and matrix synthesis [5,6].
• PDGF signaling is critical for postnatal tendon growth and remodeling, and for vascular smooth muscle cell migration in synergy with extracellular matrix proteins [2,7].
• Dysregulated PDGF responses contribute to vascular calcification, fibrosis, and cancer progression [4,5].
• CRISPR-based models (knockout, point mutation, knock-in, overexpression) enable precise dissection of PDGF pathway components in relevant cell types.
Description
The cellular response to platelet-derived growth factor (PDGF) stimulus (GO:0036120) encompasses the diverse set of molecular and cellular changes that occur when a cell encounters PDGF. PDGF is a multifunctional cytokine that acts on connective tissue cells, including fibroblasts, smooth muscle cells, and pericytes, to stimulate proliferation, migration, and extracellular matrix production [3,8]. This response is essential for normal development, tissue repair, and regeneration, but its dysregulation is implicated in numerous pathological conditions such as atherosclerosis, fibrosis, and cancer [4,5]. Understanding the precise mechanisms of PDGF signaling is therefore of broad biomedical importance. Researchers study GO:0036120 to identify the genes, signaling intermediates, and cellular outcomes that define how cells interpret and respond to PDGF. This knowledge informs the development of targeted therapies for diseases driven by aberrant PDGF signaling. The term captures a complex biological process that integrates receptor activation, intracellular signal transduction, and gene expression changes, making it a rich area for functional genomics and CRISPR-based interrogation.
cellular response to platelet-derived growth factor stimulus At A Glance
| GO ID | GO:0036120 |
|---|---|
| GO term | cellular response to platelet-derived growth factor stimulus |
| Ontology | biological_process |
| Synonym | cellular response to PDGF stimulus |
| Major function | Mediates cell proliferation, migration, secretion, and gene expression changes in response to PDGF |
| Definition source | QuickGO |
| Related stimuli | PDGF-BB, PDGF-AA, PDGF-AB isoforms |
| Key cell types | Fibroblasts, smooth muscle cells, pericytes, osteoblasts, tendon cells |
What Is GO:0036120?
GO:0036120, cellular response to platelet-derived growth factor stimulus, is defined as any process that results in a change in state or activity of a cell (in terms of movement, secretion, enzyme production, gene expression, etc.) as a result of a platelet-derived growth factor stimulus. In simpler terms, it is the entire set of cellular reactions triggered when a cell detects PDGF, a growth factor that promotes cell division, migration, and specialized functions depending on the cell type.
Why Is cellular response to platelet-derived growth factor stimulus Important in Cell Biology?
The cellular response to PDGF is a fundamental signaling axis that controls tissue homeostasis, repair, and regeneration. It is essential for embryonic development, wound healing, and the maintenance of connective tissues such as tendons and blood vessels [2,3]. Dysregulation of this response is a hallmark of many diseases, including atherosclerosis, vascular calcification, fibrosis, and various cancers [4,5]. Because PDGF signaling is highly context-dependent, understanding the precise molecular events and gene expression programs it triggers is critical for identifying therapeutic targets and biomarkers. Moreover, the pathway serves as a paradigm for how cells integrate extracellular cues into complex phenotypic changes, making it a valuable model for studying signal transduction and gene regulation.
• PDGF is a potent mitogen and chemoattractant for connective tissue cells, driving proliferation and migration [3,7].
• The response is critical for postnatal tendon growth and remodeling, as shown by genetic studies in mice.
• Pericytes secrete pro-regenerative molecules in response to PDGF-BB, highlighting a role in tissue repair.
• PDGF signaling synergizes with extracellular matrix proteins to promote vascular smooth muscle cell migration, relevant to atherosclerosis.
• Dysregulated PDGF responses contribute to vascular calcification and chronic kidney disease.
• PDGF-induced gene expression patterns serve as markers for phenotypic modulation of smooth muscle cells after injury.
• The pathway activates PI3K, which translocates to the nucleus in osteoblast-like cells, linking signaling to gene regulation.
• PDGF is a multifunctional cytokine in haemopoiesis, affecting multiple cell lineages.
• Understanding PDGF responses aids in developing therapies for fibrosis, cancer, and cardiovascular diseases.
• CRISPR screens can identify novel regulators of PDGF-dependent phenotypes, accelerating target discovery.
What Happens During cellular response to platelet-derived growth factor stimulus?
Receptor Activation and Early Signaling
In simple terms: When PDGF binds to its receptor on the cell surface, the receptor turns on and sends signals inside the cell.
The cellular response to PDGF begins with the binding of PDGF isoforms (e.g., PDGF-BB) to PDGF receptors (PDGFR-alpha and PDGFR-beta) on the cell membrane. This binding induces receptor dimerization and autophosphorylation, creating docking sites for intracellular signaling proteins. Key early events include activation of phosphatidylinositol 3-kinase (PI3K) and phospholipase C-gamma, leading to the production of second messengers. In osteoblast-like MC3T3-E1 cells, PI3K translocates to the nucleus in response to PDGF, suggesting a direct role in transcriptional regulation. These early signaling events set the stage for downstream cellular changes.
Activation of Downstream Kinase Cascades
In simple terms: The initial signal triggers a chain of protein kinases that amplify and diversify the message.
Following receptor activation, major downstream pathways include the MAPK/ERK cascade and the PI3K/Akt pathway. These kinases phosphorylate transcription factors and other effectors, leading to changes in gene expression. In vascular smooth muscle cells, PDGF differentially regulates gene expression patterns compared to hypertrophic stimuli, with distinct markers for phenotypic modulation. This differential regulation underscores the specificity of PDGF signaling in driving particular cellular outcomes, such as proliferation versus migration.
Cytoskeletal Reorganization and Cell Migration
In simple terms: The cell changes its shape and moves toward the PDGF signal.
PDGF is a potent chemoattractant, and cells respond by reorganizing their actin cytoskeleton to migrate. In human vascular smooth muscle cells, PDGF and extracellular matrix proteins (e.g., collagen, fibronectin) provide a synergistic stimulus for migration. This synergy is critical for pathological processes like neointima formation after vascular injury. The migratory response requires coordinated activation of Rho GTPases, focal adhesion kinase, and other cytoskeletal regulators downstream of PDGFR.
Secretory and Synthetic Responses
In simple terms: Cells start producing and releasing molecules that affect their surroundings.
PDGF stimulates cells to secrete various factors, including growth factors, cytokines, and extracellular matrix components. Pericytes respond to PDGF-BB by secreting pro-regenerative molecules, which can promote tissue repair. In tendon fibroblasts, PDGF receptor signaling is required for postnatal tendon growth and remodeling, partly through increased collagen synthesis. These secretory and synthetic responses are essential for tissue remodeling and can become maladaptive in disease.
Gene Expression Reprogramming
In simple terms: The cell switches many genes on or off to change its behavior.
A hallmark of the PDGF response is widespread changes in gene expression. Transcriptomic profiling of vascular smooth muscle cells treated with PDGF revealed distinct patterns of gene regulation compared to other growth stimuli, identifying markers for phenotypic modulation. These changes include induction of immediate-early genes (e.g., c-Fos, c-Myc), cell cycle regulators, and matrix metalloproteinases. The transcriptional program is orchestrated by transcription factors activated downstream of MAPK and PI3K pathways, and can be modulated by nuclear translocation of signaling molecules like PI3K.
Key Genes Involved in GO:0036120 cellular response to platelet-derived growth factor stimulus
The following genes and proteins are central to the cellular response to PDGF, based on published literature.
| Gene | Major Role | Research Relevance |
|---|---|---|
| PDGFA | PDGF-A subunit; forms PDGF-AA and PDGF-AB isoforms | Ligand for PDGFR-alpha; studied in development and fibrosis |
| PDGFB | PDGF-B subunit; forms PDGF-BB and PDGF-AB isoforms | Major mitogen for mesenchymal cells; key in vascular biology |
| PDGFC | PDGF-C subunit; forms PDGF-CC | Implicated in tissue remodeling and cancer |
| PDGFD | PDGF-D subunit; forms PDGF-DD | Regulates cell proliferation and migration |
| PDGFRA | PDGFR-alpha receptor tyrosine kinase | Binds PDGF-AA, -AB, -BB; critical in development |
| PDGFRB | PDGFR-beta receptor tyrosine kinase | Binds PDGF-BB and -AB; mediates pericyte recruitment |
| PIK3CA | PI3K catalytic subunit alpha | Mediates PI3K/Akt signaling; nuclear translocation in osteoblasts |
| PIK3CB | PI3K catalytic subunit beta | Involved in PDGF-induced signaling in various cell types |
| AKT1 | Serine/threonine kinase Akt1 | Key downstream effector of PI3K; promotes survival and proliferation |
| MAPK1 | ERK2 MAP kinase | Transduces PDGF signals to transcription factors |
| MAPK3 | ERK1 MAP kinase | Transduces PDGF signals to transcription factors |
| PLCG1 | Phospholipase C gamma 1 | Generates IP3 and DAG; regulates calcium and PKC |
| STAT3 | Signal transducer and activator of transcription 3 | Transcription factor activated by PDGF in some cells |
| JUN | AP-1 transcription factor subunit c-Jun | Immediate-early gene induced by PDGF |
| FOS | AP-1 transcription factor subunit c-Fos | Immediate-early gene induced by PDGF |
| MYC | c-Myc oncogene | Promotes cell cycle progression in response to PDGF |
| COL1A1 | Type I collagen alpha 1 chain | Matrix protein upregulated in tendon and fibrosis |
How Is cellular response to platelet-derived growth factor stimulus Regulated?
The cellular response to PDGF is tightly regulated at multiple levels. Receptor availability and activity are controlled by feedback phosphorylation, internalization, and degradation. Downstream, the PI3K/Akt pathway is antagonized by PTEN, while MAPK signaling is attenuated by dual-specificity phosphatases. In vascular smooth muscle cells, PDGF-induced gene expression is modulated by interactions with other stimuli, such as hypertrophic factors, leading to distinct phenotypic outcomes. Additionally, extracellular matrix proteins can synergize with PDGF to enhance migration, indicating that the microenvironment regulates the response. Nuclear translocation of PI3K in osteoblast-like cells suggests a direct role in transcriptional regulation, adding another layer of control. These regulatory mechanisms ensure that PDGF responses are context-specific and transient under normal conditions.
cellular response to platelet-derived growth factor stimulus and Human Disease
| Gene | Disease / Biology | Potential Experimental Model |
|---|---|---|
| PDGFB | Vascular calcification, atherosclerosis | Smooth muscle cell knockout of Pdgfb; calcification assays |
| PDGFRB | Pericyte recruitment, fibrosis | Pericyte-specific Pdgfrb knockout mice; injury models |
| PDGFRA | Tendon growth defects, fibrosis | Tendon fibroblast knockout; postnatal tendon remodeling |
| PIK3CA | Cancer, osteoblast signaling | Point mutation (e.g., E545K) knock-in in MC3T3-E1 cells |
| COL1A1 | Tendon remodeling, fibrosis | Overexpression in tendon fibroblasts; collagen assays |
Vascular Calcification and Chronic Kidney Disease
Vascular calcification is a common complication of chronic kidney disease and is associated with elevated phosphate levels. PDGF signaling contributes to the phenotypic modulation of vascular smooth muscle cells, promoting osteogenic differentiation and calcification. In this context, PDGF acts in concert with inorganic phosphate to drive pathological changes in the vessel wall. Targeting PDGF signaling may therefore offer therapeutic benefit for vascular calcification.
Atherosclerosis and Restenosis
PDGF is a key mediator of vascular smooth muscle cell migration and proliferation, processes central to atherosclerosis and restenosis after angioplasty. The synergy between PDGF and extracellular matrix proteins amplifies these responses, leading to neointimal hyperplasia. Gene expression profiling has identified PDGF-specific markers of phenotypic modulation that could serve as therapeutic targets.
Fibrosis and Tissue Remodeling
PDGF drives fibroblast proliferation and extracellular matrix production, contributing to fibrosis in multiple organs. In tendon, PDGF receptor signaling is required for postnatal growth and remodeling, but its overactivity may lead to fibrotic changes. Pericytes responding to PDGF-BB secrete pro-regenerative molecules, but in chronic injury this can exacerbate fibrosis. Understanding the balance between regenerative and fibrotic PDGF responses is critical for developing antifibrotic therapies.
Cancer
PDGF and its receptors are frequently overexpressed in various cancers, where they promote tumor cell proliferation, survival, and angiogenesis. Autocrine and paracrine PDGF signaling loops contribute to tumor progression and metastasis. The PI3K/Akt and MAPK pathways downstream of PDGFR are common targets for cancer therapy, and PDGF-induced gene expression programs overlap with oncogenic signatures [5,6].
From cellular response to platelet-derived growth factor stimulus-Related Genes to Experimental Models
| Research Question | Suitable Model |
|---|---|
| Does PDGFRB mediate pericyte secretion of pro-regenerative factors? | PDGFRB knockout in pericytes; conditioned media assays |
| Is PDGFRA required for postnatal tendon growth? | Inducible PDGFRA knockout in tendon fibroblasts; growth measurements |
| How does PI3K nuclear translocation affect PDGF-induced gene expression? | PIK3CA knockout or point mutation in osteoblast-like cells |
| What genes are differentially regulated by PDGF in smooth muscle cells? | RNA-seq after PDGF stimulation; wild-type vs. knockout |
| Does PDGF synergize with collagen to promote migration? | Knockout of PDGFRB in vascular smooth muscle cells; migration assays |
| Can overexpression of PDGF-BB drive fibrosis in vivo? | Transgenic overexpression of PDGFB in fibroblasts; fibrosis models |
How to Study the cellular response to platelet-derived growth factor stimulus Process
| Method | What It Measures | Typical Application |
|---|---|---|
| RNA-seq | Global gene expression changes | Identify PDGF-induced transcriptional programs |
| Phosphoproteomics | Phosphorylation of signaling proteins | Map kinase cascades downstream of PDGFR |
| Western blot | Protein levels and phosphorylation | Validate activation of PI3K/Akt and MAPK |
| Transwell migration | Cell migration capacity | Assess PDGF-induced chemotaxis |
| EdU incorporation | DNA synthesis / proliferation | Measure mitogenic response to PDGF |
| Cytokine array | Secretion of multiple factors | Profile pro-regenerative molecules from pericytes |
| Immunofluorescence | Subcellular localization | Detect nuclear translocation of PI3K |
| CRISPR knockout | Gene function loss | Test requirement of candidate genes in PDGF response |
Transcriptomic Profiling (RNA-seq)
RNA sequencing is widely used to capture the gene expression changes that occur during the cellular response to PDGF. By comparing PDGF-treated cells to controls, researchers can identify differentially expressed genes and pathways. This approach has been used to define markers of phenotypic modulation in vascular smooth muscle cells. Time-course experiments reveal immediate-early, early, and late gene expression programs.
Phosphoproteomics and Signaling Assays
Mass spectrometry-based phosphoproteomics enables global analysis of phosphorylation events downstream of PDGFR activation. Western blotting for phospho-Akt, phospho-ERK, and other kinases provides targeted validation. These methods are essential for mapping the signaling network and identifying feedback mechanisms. PI3K nuclear translocation can be assessed by subcellular fractionation and immunoblotting.
Cell Migration and Proliferation Assays
Functional assays such as transwell migration, scratch wound healing, and EdU incorporation measure the phenotypic outcomes of PDGF stimulation. These assays are used to study the synergistic effects of PDGF and extracellular matrix proteins on migration. They are also valuable for testing the impact of genetic perturbations (e.g., CRISPR knockout) on PDGF responses.
Secretion Profiling (Cytokine Arrays)
To study the secretory arm of the PDGF response, cytokine antibody arrays or ELISA can quantify released factors. Pericytes stimulated with PDGF-BB secrete pro-regenerative molecules that can be detected in conditioned media. This method links signaling to paracrine effects on neighboring cells.
How CRISPR Can Be Used to Study GO:0036120 cellular response to platelet-derived growth factor stimulus
Knockout
CRISPR knockout is used to delete genes encoding PDGF ligands, receptors, or downstream signaling components to determine their necessity in the cellular response. For example, knocking out PDGFRB in pericytes can abolish their secretion of pro-regenerative molecules in response to PDGF-BB. Knockout of PDGFRA in tendon fibroblasts impairs postnatal tendon growth. These models provide definitive loss-of-function evidence.
Point Mutation
Point mutations can be introduced to mimic disease-associated variants or to abrogate specific phosphorylation sites. For instance, a kinase-dead mutation in PDGFRB can distinguish between kinase-dependent and independent functions. In PIK3CA, the E545K point mutation is commonly used to model oncogenic activation and its effect on PDGF signaling. These models help dissect the contribution of individual residues to the response.
Knock-in
Knock-in of reporter tags (e.g., GFP, luciferase) or epitope tags allows real-time monitoring of protein expression and localization during PDGF stimulation. Tagging endogenous PDGFRB with a fluorescent protein enables live-cell imaging of receptor trafficking. Knock-in of a Cre recombinase under the control of the PDGFRB promoter facilitates lineage tracing of PDGF-responsive cells in vivo.
Overexpression
Overexpression of PDGF ligands or receptors can amplify the cellular response and model pathological states such as fibrosis or cancer. Transgenic overexpression of PDGFB in fibroblasts leads to fibrotic changes in multiple organs. Overexpression of constitutively active PDGFR mutants can drive ligand-independent proliferation, useful for studying downstream pathways in isolation.
How EDITGENE Supports cellular response to platelet-derived growth factor stimulus Research
Researchers studying cellular response to platelet-derived growth factor stimulus-related genes often need to determine whether a candidate gene is causally involved in PDGF-driven phenotypes such as proliferation, migration, or secretion. CRISPR-based models provide the gold standard for establishing causality, but generating these models efficiently and accurately requires specialized expertise. EDITGENE offers a comprehensive suite of CRISPR services to accelerate your PDGF research.
Contact EDITGENE today to design your custom CRISPR model for cellular response to platelet-derived growth factor stimulus research.
Frequently Asked Questions About cellular response to platelet-derived growth factor stimulus
What is GO:0036120?
GO:0036120 is the Gene Ontology term for cellular response to platelet-derived growth factor stimulus, describing all cellular changes triggered by PDGF [1,3].
What genes are involved in cellular response to platelet-derived growth factor stimulus?
Key genes include PDGFA, PDGFB, PDGFRA, PDGFRB, PIK3CA, AKT1, MAPK1, and MAPK3, among others [1,2,5,6].
What does PDGF do to cells?
PDGF stimulates proliferation, migration, secretion, and gene expression changes in connective tissue cells [3,7].
How is PDGF signaling regulated?
PDGF signaling is regulated by receptor internalization, feedback phosphorylation, PTEN, and phosphatases, as well as by interactions with extracellular matrix proteins [5,7].
What diseases are associated with PDGF signaling?
Dysregulated PDGF signaling is linked to vascular calcification, atherosclerosis, fibrosis, and cancer [4,5].
What cell types respond to PDGF?
Fibroblasts, smooth muscle cells, pericytes, osteoblasts, and tendon cells are major responders [1,2,3,6].
How can I study PDGF responses in the lab?
Common methods include RNA-seq, phosphoproteomics, migration assays, and CRISPR knockout models [5,6,7].
What is the role of PI3K in PDGF signaling?
PI3K is activated downstream of PDGFR and can translocate to the nucleus, influencing gene expression.
Does PDGF require extracellular matrix for migration?
Yes, PDGF and extracellular matrix proteins synergize to promote vascular smooth muscle cell migration.
Can CRISPR be used to study PDGF signaling?
Yes, CRISPR knockout, point mutation, knock-in, and overexpression models are powerful tools for dissecting PDGF pathway components [1,2,6].
Conclusion
The cellular response to platelet-derived growth factor stimulus (GO:0036120) is a central signaling axis that controls proliferation, migration, secretion, and gene expression in connective tissue cells. Its dysregulation underlies major human diseases, including vascular calcification, atherosclerosis, fibrosis, and cancer. Understanding the molecular mechanisms and gene expression programs triggered by PDGF is essential for developing targeted therapies. CRISPR-based models offer unprecedented opportunities to dissect this pathway with precision, and EDITGENE provides the tools and expertise to accelerate such research.
References
- 1. Gaceb A et al.. 2018. Pericytes secrete pro-regenerative molecules in response to platelet-derived growth factor-BB.. J Cereb Blood Flow Metab 38(1):45-57 PMID: 28741407
- 2. Sugg KB et al.. 2018. Postnatal tendon growth and remodeling require platelet-derived growth factor receptor signaling.. Am J Physiol Cell Physiol 314(4):C389-C403 PMID: 29341790
- 3. Ross R. 1984. Multiple responses of connective tissue cells to mitogenic stimulation with platelet-derived growth factor.. Prog Clin Biol Res 154:125-31 PMID: 6382289
- 4. Giachelli CM et al.. 2001. Vascular calcification and inorganic phosphate.. Am J Kidney Dis 38(4 Suppl 1):S34-7 PMID: 11576919
- 5. Kaplan-Albuquerque N et al.. 2005. Patterns of gene expression differentially regulated by platelet-derived growth factor and hypertrophic stimuli in vascular smooth muscle cells: markers for phenotypic modulation and response to injury.. J Biol Chem 280(20):19966-76 PMID: 15774477
- 6. Martelli AM et al.. 2000. Phosphatidylinositol 3-kinase translocates to the nucleus of osteoblast-like MC3T3-E1 cells in response to insulin-like growth factor I and platelet-derived growth factor but not to the proapoptotic cytokine tumor necrosis factor alpha.. J Bone Miner Res 15(9):1716-30 PMID: 10976992
- 7. Nelson PR et al.. 1997. Platelet-derived growth factor and extracellular matrix proteins provide a synergistic stimulus for human vascular smooth muscle cell migration.. J Vasc Surg 26(1):104-12 PMID: 9240328
- 8. Haworth C. 1989. Multifunctional cytokines in haemopoiesis.. Blood Rev 3(4):263-8 PMID: 2692746
